| Sairah Ahmed, M.D. |
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Office Address
The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd. Unit 423
Houston, TX 77030
Phone: 713-792-8750
Fax: (713)794-4902
1515 Holcombe Blvd. Unit 423
Houston, TX 77030
Phone: 713-792-8750
Fax: (713)794-4902
Education & Training
Degree-Granting Education | |
| 2000 | Khyber Medical College, Peshawar, Pakistan, MBBS, Bachelor of Medicine, Bachelor of Surgery |
Postgraduate Training | |
| 7/2011-7/2012 | Clinical Fellowship, Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, Marcos deLima, M.D. |
| 1/2011-3/2011 | Rotating Faculty, Hematology/Oncology, Shaukat Khanum Memorial Cancer Hospital & Research Center, Lahore, Pakistan |
| 7/2007-7/2012 | Clinical Fellowship, Hematology/Oncology, Northwestern University, Feinberg School of Medicine, Chicago, IL, William Gradishar |
| 7/2007-7/2008 | Chief Fellow, Hematology/Oncology, Northwestern University, Feinberg School of Medicine, Chicago, IL, William Gradishar |
| 7/2006-6/2007 | Chief Medical Resident, Primary Care Internal Medicine Program, University of Connecticut, Farmington, CT, Scott Allen, MD |
| 4/2005-5/2005 | Rotation, Bone Marrow and Stem Cell Transplant, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA |
| 7/2003-6/2006 | Internship & Residency in Internal Medicine, Primary Care Internal Medicine Program, University of Connecticut, Farmington, CT, Scott Allen, MD |
| 1/2001-3/2002 | Clinical Internship, Pediatrics and Medicine, Khyber Teaching Hospital, Peshawar, Pakistan |
Board Certifications
| 11/2010 | American Board of Internal Medicine - Hematology |
| 11/2010 | American Board of Internal Medicine - Medical Oncology |
| 9/2006 | American Board of Internal Medicine - Internal Medicine |
Honors and Awards
| 2011 | Fellows Award Recipient, Hematologia del Instituto Nacional de Cancerologia Mexico, Cancun, Mexico |
| 2010 | Fellows Award Recipient, Mayo Clinic - Jacksonville |
| 2009 | ASCO Fellows Recognition Program, American Society of Clinical Oncology |
| 2009 | Northwestern University Fellow Teaching Award, Northwestern University |
| 2008 | NCCN Fellows Recognition Program, National Comprehensive Cancer Network |
| 2007 | Paul Paladino Award of Excellence for Chief Resident, University of Connecticut |
| 2003-2004 | Letter of Commendaton for Excellence in Patient Care, Universitiy of Connecticut |
Selected Publications
Peer-Reviewed Original Research Articles | |
| 1. | Ahmed S, Winter J, Gordon L, Evens A. Radioimmunotherapy for the Treatment of Non-Hodgkin Lymphoma: Current Status and Future Applications. Leukemia and Lymphoma 51(7):1163-1177, 7/2010. |
Abstracts | |
| 1. | Ahmed S, Saliba R, de Lima M, Fisher T, Rondon G, Kebriaei P, Alousi A, Hosing C, Bashir Q, Andersson B, Champlin R. International Consensus Criteria for Tyrosine Kinase Inhibitor Response and Outcome of Allogeneic Stem Cell Transplantation for. Blood 120(21) (#1997), 11/2012. |
| 2. | Ahmed S, Saliba R, de Lima M, Rondon G, Kebriaei P, Fiser T, Jabbour E, Chen J, Kantarjian H, Anderlini P, Alousi A, Hosing C, Andersson B, Jones R, Qazilbash M, Shpall E, Giralt S, Champlin R. Sequential Treatment After Allogeneic Stem Cell Transplantation for Chronic Myelogenous Leukemia. Blood 120(21) (#3129), 11/2012. |
| 3. | Ahmed S, Evens A, Bhalla S, Amareshwar S, James C, Yang S, Prachand S, Dokic D, Gascoyne R, Winter J, Schumacker P, Gordon L. Hypoxia Inducible Factor 1a (HIF-1a) Regulates CD20 Expression in Lymphoma Cells: Possible Implications for Rituximab Based Therapy in Diffuse Large B Cell Lymphoma (DLBCL). Blood 114 (#1698), 11/2009. |
| 4. | Bhalla S, Gordon L, Amareshwar S, Ahmed S, Dokic D, James C, Schumacker P, Evens A. PX-478, a Novel Small Molecule Inhibitor of Hypoxia Inducible Factor-1 (HIF-1) Downregulates HIF and Induces Cytotoxicity in Diffuse Large B Cell Lymphoma Cells. Blood 114 (#2713), 11/2009. |
Grant & Contract Support
| Funding Source: | NIH/NCI |
| Role: | Postdoctoral Fellow |
| Principal Investigator: | Leo Gordon, M.D. |
| Duration: | 7/2008 - 7/2010 |
Last updated: 3/12/2013
- Global Navigation
- About Us
- Locations
- Calendar
- Careers
- Publications
- How You Can Help
- Contact Us
- Newsroom
- Site Index
- Patient and Cancer Information
- myMDAnderson
- Cancer Information
- Patient Information
- Care Centers & Clinics
- Children's Cancer Hospital
- Services & Amenities
- Education and Research
- Departments, Programs and Labs
- PeopleFinder
- Research at MD Anderson
- Education & Training
- Resources for Professionals
- For Employees
- Employee Alert Information
- Employee Resources
- Doing Business
- Vendors & Suppliers
- Partners & Affiliates
- Legal and Policy
- Legal Statements
- Site Policies
- Reporting Fraud, Waste & Abuse
© 2010 The University of Texas M. D. Anderson Cancer Center

